Healthcare DIVE November 1, 2023
The startup was once valued at $4 billion during the height of the digital health funding boom.
Dive Brief:
- Olive, a healthcare AI startup that was once valued at $4 billion, announced on Tuesday that the company will shut down.
- The startup, which sold revenue cycle automation tools, will sell its clearinghouse and patient access businesses to Waystar and Humata Health. Those units represent “the heart of Olive’s business,” and the company will wind down the rest of its operations.
- Olive had previously raised hundreds of millions of dollars, including a $400 million funding round, at the height of the digital health funding boom in 2021.
Dive Insight:
Olive’s shutdown is the latest digital health powerhouse...